PE20081893A1 - Subtipo de amidas selectivas de diazabicicloalcanos - Google Patents
Subtipo de amidas selectivas de diazabicicloalcanosInfo
- Publication number
- PE20081893A1 PE20081893A1 PE2008000461A PE2008000461A PE20081893A1 PE 20081893 A1 PE20081893 A1 PE 20081893A1 PE 2008000461 A PE2008000461 A PE 2008000461A PE 2008000461 A PE2008000461 A PE 2008000461A PE 20081893 A1 PE20081893 A1 PE 20081893A1
- Authority
- PE
- Peru
- Prior art keywords
- diazabicycle
- heptane
- ilcarbonyl
- methylfuran
- diazabicicloalkanes
- Prior art date
Links
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 abstract 10
- 150000001875 compounds Chemical class 0.000 abstract 3
- -1 3-THENYL Chemical class 0.000 abstract 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 206010039966 Senile dementia Diseases 0.000 abstract 1
- KPCZJLGGXRGYIE-UHFFFAOYSA-N [C]1=CC=CN=C1 Chemical class [C]1=CC=CN=C1 KPCZJLGGXRGYIE-UHFFFAOYSA-N 0.000 abstract 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 abstract 1
- 229960004373 acetylcholine Drugs 0.000 abstract 1
- 206010013932 dyslexia Diseases 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 230000001537 neural effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
SE REFIERE A COMPUESTOS DERIVADOS DE DIAZABICICLOALCANOS DE FORMULA (1) A-C(O)-Ci DONDE A ES UN CENTRO DIAZABICICLICO DE 7, 8 O 9 MIEMBROS TALES COMO 2,6-DIAZABICICLO[3.2.0]HEPTANO, 3,7-DIAZABICICLO[4.2.0]OCTANO, 2,7-DIAZABICICLO[3.3.0]OCTANO, ENTRE OTROS; Ci ES UN HETEROARILO TAL COMO 2-FURANILO, 3-TIENILO, 2-OXAZOLILO, 1,3,4-OXADIAZOL-2-IL, 3-PIRIDINIL, ENTRE OTROS, OPCIONALMENTE SUSTITUIDOS CON HALOGENO, CN, NO2, N3, ENTRE OTROS SUSTITUYENTES. SON COMPUESTOS PREFERIDOS: 6-(FURAN-2-ILCARBONIL)-2,6-DIAZABICICLO[3.2.0]HEPTANO, 2-(3-METILFURAN-2-ILCARBONIL)-2,6-DIAZABICICLO[3.2.0]HEPTANO, 6-(3-METILFURAN-2-ILCARBONIL)-2,6-DIAZABICICLO[3.2.0]HEPTANO, 2-(5-METILFURAN-2-ILCARBONIL)-2,6-DIAZABICICLO[3.2.0]HEPTANO, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON MODULADORES DE RECEPTORES DE ACETILCOLINA NICOTINICOS NEURONALES SIENDO UTILES EN EL TRATAMIENTO DE DEMENCIA SENIL, ESQUIZOFRENIA, DISLEXIA
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90676207P | 2007-03-13 | 2007-03-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20081893A1 true PE20081893A1 (es) | 2009-02-15 |
Family
ID=39580235
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2008000461A PE20081893A1 (es) | 2007-03-13 | 2008-03-12 | Subtipo de amidas selectivas de diazabicicloalcanos |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20100144700A1 (es) |
| AR (1) | AR065705A1 (es) |
| CL (1) | CL2008000726A1 (es) |
| PE (1) | PE20081893A1 (es) |
| TW (1) | TW200840569A (es) |
| UY (1) | UY30959A1 (es) |
| WO (1) | WO2008112734A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010028033A1 (en) * | 2008-09-05 | 2010-03-11 | Targacept, Inc. | Amides of diazabicyclooctanes and uses thereof |
| AU2010262643B2 (en) * | 2009-06-19 | 2015-02-19 | Abbvie Inc. | Diazahomoadamantane derivatives and methods of use thereof |
| CN102648202A (zh) * | 2009-12-07 | 2012-08-22 | 塔加西普特公司 | 作为神经元烟碱乙酰胆碱受体配体的3,6-二氮杂双环[3.1.1]庚烷 |
| EP3154974B1 (en) * | 2014-06-13 | 2018-11-14 | Bristol-Myers Squibb Company | Tricyclic compounds as alpha- 7 nicotinic acetylcholine receptor ligands |
| CA2997545C (en) * | 2015-09-04 | 2022-01-11 | Janssen Pharmaceutica Nv | Therapeutic compounds for pain and synthesis thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7135484B2 (en) * | 2002-08-14 | 2006-11-14 | Abbott Laboratories | Azabicyclic compounds are central nervous system active agents |
| US7399765B2 (en) * | 2003-09-19 | 2008-07-15 | Abbott Laboratories | Substituted diazabicycloalkane derivatives |
| EP1697378B1 (en) * | 2003-12-22 | 2007-11-21 | Memory Pharmaceuticals Corporation | Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof |
| CN101248073A (zh) * | 2005-08-22 | 2008-08-20 | 塔加西普特公司 | 杂芳基-取代的二氮杂三环烷类、其制备方法及其应用 |
-
2008
- 2008-02-29 TW TW097107240A patent/TW200840569A/zh unknown
- 2008-03-12 AR ARP080101013A patent/AR065705A1/es not_active Application Discontinuation
- 2008-03-12 WO PCT/US2008/056607 patent/WO2008112734A1/en not_active Ceased
- 2008-03-12 US US12/530,997 patent/US20100144700A1/en not_active Abandoned
- 2008-03-12 CL CL200800726A patent/CL2008000726A1/es unknown
- 2008-03-12 UY UY030959A patent/UY30959A1/es not_active Application Discontinuation
- 2008-03-12 PE PE2008000461A patent/PE20081893A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CL2008000726A1 (es) | 2008-06-06 |
| US20100144700A1 (en) | 2010-06-10 |
| WO2008112734A1 (en) | 2008-09-18 |
| AR065705A1 (es) | 2009-06-24 |
| TW200840569A (en) | 2008-10-16 |
| UY30959A1 (es) | 2009-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20170666A1 (es) | 2-(morfolin-4-il)-1,7-naftiridinas | |
| PE20140703A1 (es) | Derivados de heteroarilo como moduladores de nachr alfa 7 | |
| PE20160664A1 (es) | Compuestos heteroaromaticos y su uso como ligandos d1 de dopamina | |
| PE20141283A1 (es) | Nuevos derivados biciclicos de dihidroisoquinolin-1-ona | |
| EA201071234A1 (ru) | Производные изохинолинона в качестве nk3 антагонистов | |
| PE20210667A1 (es) | Derivados de benzamida para la inhibicion de la actividad abl1, abl2 y bcr-abl1 | |
| PE20130184A1 (es) | Compuesto heterociclico | |
| PE20081441A1 (es) | Subtipo de amidas selectivas de diazabicicloalcanos | |
| PE20090679A1 (es) | Derivados de azaciclilisoquinolinona e isoindolinona como antagonistas de histamina-3 | |
| PE20141203A1 (es) | Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas | |
| PE20171177A1 (es) | Compuestos aminopirimidinilo inhibidores de jak | |
| PE20121500A1 (es) | 2-amino-5,5-difluor-5,6-dihidro-4h-oxazinas como inhibidores de bace 1 y/o bace 2 | |
| PE20140934A1 (es) | Derivados de pirazol | |
| EA201691428A1 (ru) | Бициклические гетероциклические производные в качестве ингибиторов irak4 | |
| AR059957A1 (es) | DERIVADOS DE ESPIROINDOLINONA, MÉTODOS PARA SU PREPARACIoN, UNA COMPOSICIoN FARMACÉUTICA QUE LOS CONTIENE Y SU USO EN LA FABRICACIoN DE MEDICAMENTOS PARA EL TRATAMIENTO DEL CÁNCER. | |
| PE20171057A1 (es) | Derivados espirodiamina como inhibidores de la aldosterona sintasa | |
| PE20091734A1 (es) | Compuestos de 2-imino-3-metilpirrolopirimidinona fenilo-sustituida como inhibidores de bace-1, composiciones y su uso | |
| MX2010006893A (es) | Derivados de benzotiazol y benzoxazol y metodos de uso. | |
| PE20131143A1 (es) | Nuevas aminopirazoloquinazolinas | |
| NO20083909L (no) | Bisykliske benzimidazolforbindelser, og deres anvendelse som metabotropiske glutamatreseptorforsterkere | |
| EA201592082A1 (ru) | 3,4-дигидроизохинолин-2(1h)-ильные соединения | |
| PE20191142A1 (es) | 2,4 diamino-quinolina sustituida como nuevos agentes anti-cancerigenos | |
| PE20161476A1 (es) | Derivados de indolin-2-ona o pirrolo-piridin-2-ona | |
| PE20141380A1 (es) | Imidazopiridazinas como inhibidores de quinasa akt | |
| EA201490493A1 (ru) | Пирано[3,2-d][1,3]тиазол в качестве ингибиторов гликозидазы |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FX | Voluntary withdrawal |